LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Simple Blood Test Used as Tool for Early Cancer Diagnosis

By LabMedica International staff writers
Posted on 15 Oct 2014
Image: Photomicrograph of small cell carcinoma of the ovary hypercalcemic type (Photo courtesy of Nephron).
Image: Photomicrograph of small cell carcinoma of the ovary hypercalcemic type (Photo courtesy of Nephron).
High levels of calcium in blood, a condition known as hypercalcemia, can be used by general practitioners and physicians as an early indication of certain types of cancer.

A simple blood test could identify those with hypercalcemia, which is the most common metabolic disorder associated with cancer, occurring in 10% to 20 % of people with cancer and can often predate the diagnosis of cancer in primary care.

Scientists at the University of Bristol (UK) carried out a retrospective cohort study of patients aged greater than or equal to 40 years who were age- and sex-matched controls to case patients with 1 of 13 common cancers. The data included all diagnoses and laboratory investigations from primary care. They analyzed the electronic records of 54,000 patients who had elevated levels of calcium and looked at how many of them went on to receive a cancer diagnosis.

Analysis of the data from 54,000 patients found that in men, even mild hypercalcemia of 2.6 to 2.8 mmol/L conferred a risk of cancer in one year of 11%. If the calcium was greater than 2.8 mmol/L, the risk increased to 28%. In women, the risks were much less, with the corresponding figures being 4.1% and 8.7%. In men, 81% of the cancer associated with hypercalcemia was caused by lung, prostate, myeloma, colorectal, and other hematological cancers, but in women, cancer was much less common. There was no difference between the calcium levels in the different cancers

Fergus Hamilton, PhD, the senior author of the study said, “All previous studies on hypercalcemia and cancer had been carried out with patients who had already been diagnosed with cancer, hypercalcemia was seen as a late effect of the cancer. We wanted to look at the issue from a different perspective and find out if high calcium levels in blood could be used as an early indicator of cancer and therefore in the diagnosis of cancer. We were surprised by the gender difference. There are a number of possible explanations for this but we think it might be because women are much more likely to have hyperparathyroidism, another cause of hypercalcaemia. Men rarely get this condition, so their hypercalcemia is more likely to be due to cancer.” The study was published on August 5, 2014, in the British Journal of Cancer.

Related Links:

University of Bristol


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more